in this study we compared the effects of systemic administration of haloperidol ( hal ) , a typical dopaminergic antagonist and of domperidone ( dom ) , a dopamine ( da ) receptor blocker which does not cross the blood brain barrier but has a potency similar to hal at da receptors , on hypothalamic and striatal da system turnover ( evaluated by means of hva and dopac levels ) and prolactin ( prl ) secretion in male rats .
C0282151
dopaminergic
C0013030
da